Literature DB >> 10579327

Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone.

D Chrysis1, L E Underwood.   

Abstract

To investigate whether the anabolic effects of insulin-like growth factor I (IGF-I) and GH are mediated through regulation of the ubiquitin (Ub) pathway, we examined the effect of IGF-I (0.35 microg/100 g) and/or GH (0.3 mg/100 g BW) on the expression of Ub and Ub-conjugating (E2) enzyme messenger RNAs (mRNAs) in skeletal muscle of rats made catabolic by treatment with dexamethasone (Dex; 0.5 mg/100 g BW) for 3 days. Dex caused a significant loss of body and gastrocnemius weight (14% and 25%, respectively) concurrent with an increase in the 2.8- and 1.2-kb transcripts of Ub (14.3- and 12-fold increases, respectively), the 1.8- and 1.2-kb transcripts of 14-kDa Ub-conjugating enzyme (E2-14 kDa; 5.6- and 7.7-fold increases, respectively), the 4.4- and 2.4-kb transcripts of Ub-E2G (6.5- and 8.2-fold increases, respectively), and the 2E isoform of the 17-kDa E2 mRNA (3.5-fold increase). Injections of IGF-I in Dex-treated animals ameliorated the body weight loss, and the gastrocnemius tended to be heavier. This improvement was also accompanied by a significant suppression of transcripts for Ub (58% and 66% decreases), E2-14 kDa (58% and 68% decreases), and Ub-E2G (78% decrease), whereas the 2E isoform of the 17-kDa E2 was only modestly affected (20% decrease). GH restored serum IGF-I levels to normal in Dex-treated rats, but had no effect on the body weight loss or on any of the studied components of the Ub pathway. Administration of IGF-I to the Dex/GH-treated animals decreased the activated mRNAs of the Ub pathway in a manner and degree similar to those observed in the Dex/ IGF-I group. In summary, these results provide evidence that IGF-I regulates the expression of mRNAs encoding components of the Ub pathway during catabolism and suggest a possible mechanism for the antiproteolytic actions of IGF-I. On the other hand, GH, which is believed not to affect proteolysis but only protein synthesis, had no effect on any of the mRNAs studied.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579327     DOI: 10.1210/endo.140.12.7217

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

Authors:  Paul Gregorevic; David R Plant; Kerri S Leeding; Leon A Bach; Gordon S Lynch
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles.

Authors:  Lydie Combaret; Daniel Taillandier; Dominique Dardevet; Daniel Béchet; Cécile Rallière; Agnès Claustre; Jean Grizard; Didier Attaix
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

Review 3.  [Cellular regulation of anabolism and catabolism in skeletal muscle during immobilisation, aging and critical illness].

Authors:  Eva-Maria Strasser; Barbara Wessner; Erich Roth
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 4.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

5.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

Authors:  M D Gomes; S H Lecker; R T Jagoe; A Navon; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation.

Authors:  Aldrin V Gomes; Dave S Waddell; Rylie Siu; Matthew Stein; Shannamar Dewey; J David Furlow; Sue C Bodine
Journal:  FASEB J       Date:  2012-04-16       Impact factor: 5.191

7.  Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner.

Authors:  D Chrysis; A S Calikoglu; P Ye; A J D'Ercole
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

8.  FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy.

Authors:  Bin Zheng; Sakae Ohkawa; Haiyan Li; Tiffany K Roberts-Wilson; S Russ Price
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

Review 9.  Deubiquitinases in skeletal muscle atrophy.

Authors:  Simon S Wing
Journal:  Int J Biochem Cell Biol       Date:  2013-05-13       Impact factor: 5.085

10.  Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration.

Authors:  John E Cho; Mario Fournier; Xiaoyu Da; Michael I Lewis
Journal:  J Appl Physiol (1985)       Date:  2009-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.